Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00733460 · ClinicalTrials.gov registry record · Phase 1
A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET
A Phase 1 study, sponsored by Fluoropharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00733460 is a Phase 1 study that has completed, run by Fluoropharma. The registered enrollment target is 12 participants.
The verdict
NCT00733460, a Phase 1 study, has completed, sponsored by Fluoropharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Safety and dosimetry of BFPET™ will be evaluated in healthy volunteers and Coronary Artery Disease (CAD) patients , male or female and of age ranging between 20-80 years old.
Interventions
- DRUG BFPET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00733460
The ClinicalTrials.gov registry entry for NCT00733460 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fluoropharma, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BFPET is the first listed.
NCT00733460 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00733460 about?
NCT00733460 is a clinical study titled "A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET". Safety and dosimetry of BFPET™ will be evaluated in healthy volunteers and Coronary Artery Disease (CAD) patients , male or female and of age ranging between 20-80 years old.
What is the current status of trial NCT00733460?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2008-03. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00733460?
The interventions under investigation include: BFPET (DRUG).
Who is sponsoring clinical trial NCT00733460?
This trial is sponsored by Fluoropharma, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.